ZFTA–RELA ependymomas make itaconate to epigenetically drive fusion expression
Nature - The ZFTA–RELA fusion, an oncogene for ependymomas, promotes the production of itaconate, and its dependence on this metabolite represents a new therapeutic target for this cancer.
nature.com